94 related articles for article (PubMed ID: 12738746)
1. Cyclin d1 overexpression sensitizes breast cancer cells to fenretinide.
Pirkmaier A; Yuen K; Hendley J; O'Connell MJ; Germain D
Clin Cancer Res; 2003 May; 9(5):1877-84. PubMed ID: 12738746
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model.
Ishii Y; Pirkmaier A; Alvarez JV; Frank DA; Keselman I; Logothetis D; Mandeli J; O'Connell MJ; Waxman S; Germain D
J Natl Cancer Inst; 2006 Sep; 98(17):1238-47. PubMed ID: 16954476
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen stimulates the growth of cyclin D1-overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3.
Ishii Y; Waxman S; Germain D
Cancer Res; 2008 Feb; 68(3):852-60. PubMed ID: 18245487
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of cyclin DI contributes to malignant properties of esophageal tumor cells by increasing VEGF production and decreasing Fas expression.
Shintani M; Okazaki A; Masuda T; Kawada M; Ishizuka M; Doki Y; Weinstein IB; Imoto M
Anticancer Res; 2002; 22(2A):639-47. PubMed ID: 12014632
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice.
Wang Y; Thakur A; Sun Y; Wu J; Biliran H; Bollig A; Liao DJ
Cancer Res; 2007 Apr; 67(8):3698-707. PubMed ID: 17440082
[TBL] [Abstract][Full Text] [Related]
6. Prolonged response to antisense cyclin D1 in a human squamous cancer xenograft model.
Sauter ER; Herlyn M; Liu SC; Litwin S; Ridge JA
Clin Cancer Res; 2000 Feb; 6(2):654-60. PubMed ID: 10690551
[TBL] [Abstract][Full Text] [Related]
7. Constitutive overexpression of cyclin D1 does not prevent inhibition of hormone-responsive human breast cancer cell growth by antiestrogens.
Pacilio C; Germano D; Addeo R; Altucci L; Petrizzi VB; Cancemi M; Cicatiello L; Salzano S; Lallemand F; Michalides RJ; Bresciani F; Weisz A
Cancer Res; 1998 Mar; 58(5):871-6. PubMed ID: 9500441
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of anchorage-independent cell growth, adhesion, and cyclin D1 gene expression by a dominant negative mutant of a tyrosine phosphatase.
Mitra SK; Swarup G
Exp Cell Res; 2001 Oct; 270(1):32-44. PubMed ID: 11597125
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
Li H; Weinstein IB
Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886
[TBL] [Abstract][Full Text] [Related]
10. Specific protection against breast cancers by cyclin D1 ablation.
Yu Q; Geng Y; Sicinski P
Nature; 2001 Jun; 411(6841):1017-21. PubMed ID: 11429595
[TBL] [Abstract][Full Text] [Related]
11. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 overexpression enhances radiation-induced apoptosis and radiosensitivity in a breast tumor cell line.
Coco Martin JM; Balkenende A; Verschoor T; Lallemand F; Michalides R
Cancer Res; 1999 Mar; 59(5):1134-40. PubMed ID: 10070974
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 is necessary but not sufficient for anchorage-independent growth of rat mammary tumor cells and is associated with resistance of the Copenhagen rat to mammary carcinogenesis.
Li YJ; Song R; Korkola JE; Archer MC; Ben-David Y
Oncogene; 2003 May; 22(22):3452-62. PubMed ID: 12776197
[TBL] [Abstract][Full Text] [Related]
14. Suppression of Neu-induced mammary tumor growth in cyclin D1 deficient mice is compensated for by cyclin E.
Bowe DB; Kenney NJ; Adereth Y; Maroulakou IG
Oncogene; 2002 Jan; 21(2):291-8. PubMed ID: 11803472
[TBL] [Abstract][Full Text] [Related]
15. Requirement for CDK4 kinase function in breast cancer.
Yu Q; Sicinska E; Geng Y; Ahnström M; Zagozdzon A; Kong Y; Gardner H; Kiyokawa H; Harris LN; Stål O; Sicinski P
Cancer Cell; 2006 Jan; 9(1):23-32. PubMed ID: 16413469
[TBL] [Abstract][Full Text] [Related]
16. Transduction of antisense cyclin D1 using two-step gene transfer inhibits the growth of rat hepatoma cells.
Uto H; Ido A; Moriuchi A; Onaga Y; Nagata K; Onaga M; Tahara Y; Hori T; Hirono S; Hayashi K; Tsubouchi H
Cancer Res; 2001 Jun; 61(12):4779-83. PubMed ID: 11406552
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
[TBL] [Abstract][Full Text] [Related]
18. Is Cyclin D1-CDK4 kinase a bona fide cancer target?
Malumbres M; Barbacid M
Cancer Cell; 2006 Jan; 9(1):2-4. PubMed ID: 16413464
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells.
Al Moustafa AE; Foulkes WD; Wong A; Jallal H; Batist G; Yu Q; Herlyn M; Sicinski P; Alaoui-Jamali MA
Oncogene; 2004 Jul; 23(30):5252-6. PubMed ID: 15229656
[TBL] [Abstract][Full Text] [Related]
20. Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression.
Yang C; Trent S; Ionescu-Tiba V; Lan L; Shioda T; Sgroi D; Schmidt EV
Cancer Res; 2006 Dec; 66(24):11649-58. PubMed ID: 17178859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
